FDA to Review Vaccine Trial Protocols Following Child Death Reports

A senior vaccine official at the U.S. Food and Drug Administration (FDA) has announced a review of vaccine trial procedures. This follows reports of ten child deaths potentially linked to COVID-19 vaccines. In an internal memo, the FDA's top vaccine regulator stated the agency will seek stricter review and approval protocols for future trials. The goal is to ensure the highest safety standards are met. The announcement comes after physicians requested verified proof connecting the vaccines to the fatalities. The FDA's planned changes aim to strengthen public confidence in the vaccine development process.